Skip to main content
. 2020 Jun 29;35(3):835–849. doi: 10.1038/s41375-020-0917-7

Fig. 5. Distribution of risk groups according to different classification and prognostic tools for treated versus untreated patients.

Fig. 5

a Comparison of IPSS-R risk-groups between treated and untreated patients. b Comparison of IPSS-R cytogenetic risk-groups between treated and untreated patients. c Comparison of WHO subgroups between treated and untreated patients.